These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6475891)

  • 1. Strategies to improve compliance with narcotic antagonists.
    Kosten TR; Kleber HD
    Am J Drug Alcohol Abuse; 1984; 10(2):249-66. PubMed ID: 6475891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone induction: psychologic and pharmacologic strategies.
    Kleber HD; Kosten TR
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):29-38. PubMed ID: 6469934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone: a clinical perspective.
    Greenstein RA; Arndt IC; McLellan AT; O'Brien CP; Evans B
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):25-8. PubMed ID: 6469933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of narcotic antagonists in the rehabilitation of opiate addicts: a review of naltrexone.
    Schecter A
    Am J Drug Alcohol Abuse; 1980; 7(1):1-18. PubMed ID: 6254356
    [No Abstract]   [Full Text] [Related]  

  • 5. Naltrexone: a short-term treatment for opiate dependence.
    Greenstein RA; O'Brien CP; McLellan AT; Woody GE; Grabowski J; Long M; Coyle-Perkins G; Vittor A
    Am J Drug Alcohol Abuse; 1981; 8(3):291-300. PubMed ID: 7340503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone, opiate addiction, and endorphins.
    Gold MS; Dackis CA; Pottash AL; Sternbach HH; Annitto WJ; Martin D; Dackis MP
    Med Res Rev; 1982; 2(3):211-46. PubMed ID: 6289026
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with naltrexone in suburban opioid addicts.
    Tennant FS; Rawson RA; Cohen AJ; Mann A
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial factors in outcome in two opiate addiction treatments.
    Grey C; Osborn E; Reznikoff M
    J Clin Psychol; 1986 Jan; 42(1):185-9. PubMed ID: 3950006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
    Sullivan MA; Rothenberg JL; Vosburg SK; Church SH; Feldman SJ; Epstein EM; Kleber HD; Nunes EV
    Am J Addict; 2006; 15(2):150-9. PubMed ID: 16595353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.
    Charney DS; Riordan CE; Kleber HD; Murburg M; Braverman P; Sternberg DE; Heninger GR; Redmond DE
    Arch Gen Psychiatry; 1982 Nov; 39(11):1327-32. PubMed ID: 7138234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare.
    Rawson RA; Washton AM; Resnick RB; Tennant FS
    Adv Alcohol Subst Abuse; 1984; 3(3):41-9. PubMed ID: 6093484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate withdrawal.
    Farrell M
    Addiction; 1994 Nov; 89(11):1471-5. PubMed ID: 7841858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The index of choice: indications of methadone patients' selection of naltrexone treatment.
    Singleton EG; Sherman MF; Bigelow GE
    Am J Drug Alcohol Abuse; 1984; 10(2):209-21. PubMed ID: 6475888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of naltrexone to extinguish opioid-conditioned responses.
    O'Brien CP; Childress AR; McLellan AT; Ternes J; Ehrman RN
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):53-6. PubMed ID: 6381473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotherapy/counseling for opiate addicts: strategies for use in different treatment settings.
    Rounsaville BJ; Kleber HD
    Int J Addict; 1985; 20(6-7):869-96. PubMed ID: 3908340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates.
    Loimer N; Lenz K; Schmid R; Presslich O
    Am J Psychiatry; 1991 Jul; 148(7):933-5. PubMed ID: 2053636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems in methadone treatment: the influence of reference groups.
    Hunt DE; Lipton DS; Goldsmith DS; Strug DL
    NIDA Res Monogr; 1984; 46():8-22. PubMed ID: 6427626
    [No Abstract]   [Full Text] [Related]  

  • 19. Naltrexone in addicted business executives and physicians.
    Washton AM; Pottash AC; Gold MS
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):39-41. PubMed ID: 6088468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone.
    Kosten TR; Morgan C; Kleber HD
    NIDA Res Monogr; 1992; 121():101-19. PubMed ID: 1406906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.